Bonnington Adam, Dianat Shokoufeh, Kerns Jennifer, Hastings Jen, Hawkins Mitzi, De Haan Gene, Obedin-Maliver Juno
Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco 550 16th Street, San Francisco, CA 94158, USA.
Department of Family & Community Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences. Zuckerberg San Francisco General Hospital, 1001 Potrero Ave, San Francisco, CA 94110, USA.
Contraception. 2020 Aug;102(2):70-82. doi: 10.1016/j.contraception.2020.04.001. Epub 2020 Apr 15.
Everyone of reproductive potential, no matter sex or gender, may have contraceptive needs. However, with no professional society guidelines and scant data on contraceptive use for transgender and gender-diverse (TGD) populations, clinicians' abilities to counsel patients on use, safety, side effects, and efficacy is severely limited. We know very little about how estrogen- and progestin-containing contraceptive methods interact with gender-affirming testosterone therapy. Consequently, providers must extrapolate from data on use of hormonal contraceptive methods in presumed cisgender women and rely on clinical expertise. Based on available literature and expert opinion, there are important considerations for each method that can help guide contraceptive counseling with TGD patients. Specific considerations include differential experience of side-effects in TGD patients, barriers to access, and potential misconceptions regarding menstruation and reproductive capacity. When counseling a TGD person about their contraception options, providers should engage in shared decision-making, acknowledging the spectrum of identities and experiences within these communities. In order to support gender-affirming patient-centered care, providers should also create a space that is welcoming, use language that promotes inclusivity, and perform physical exams that consider the potential physical and emotional discomforts specific to these patients. Given the lack of population-specific data and guidelines, we encourage providers to integrate what is known about contraceptive use in cisgender women with the unique needs of TGD persons to apply a shared decision-making contraceptive counseling approach with members of these communities.
每一个具有生殖潜力的人,无论性别如何,都可能有避孕需求。然而,由于缺乏专业协会指南,且关于跨性别者和性别多样化(TGD)人群避孕使用的数据极少,临床医生在为患者提供关于避孕方法的使用、安全性、副作用和有效性的咨询方面的能力受到严重限制。我们对含雌激素和孕激素的避孕方法如何与性别确认性睾酮治疗相互作用知之甚少。因此,医疗服务提供者必须从假定为顺性别女性使用激素避孕方法的数据中进行推断,并依靠临床专业知识。根据现有文献和专家意见,每种方法都有重要的考虑因素,可帮助指导对TGD患者的避孕咨询。具体考虑因素包括TGD患者副作用的不同体验、获取障碍以及对月经和生殖能力的潜在误解。在为TGD人群提供避孕选择咨询时,医疗服务提供者应参与共同决策,承认这些群体中的身份和经历范围。为了支持以性别确认患者为中心的护理,医疗服务提供者还应营造一个友好的空间,使用促进包容性的语言,并进行考虑到这些患者特有的潜在身体和情绪不适的身体检查。鉴于缺乏针对特定人群的数据和指南,我们鼓励医疗服务提供者将已知的顺性别女性避孕使用情况与TGD人群的独特需求相结合,以便对这些群体的成员采用共同决策的避孕咨询方法。